Analysts Set Semler Scientific Inc. (NASDAQ:SMLR) Price Target at $74.25

Semler Scientific Inc. (NASDAQ:SMLR) has earned a consensus rating of “Moderate Buy” from the five brokerages that are presently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average 1 year price target among analysts that have covered the stock in the last year is $74.25.

Several brokerages have recently weighed in on SMLR. Benchmark dropped their price objective on shares of Semler Scientific from $101.00 to $86.00 and set a “buy” rating on the stock in a report on Tuesday, September 23rd. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Semler Scientific in a research note on Monday, December 29th. Finally, Maxim Group cut their price target on Semler Scientific from $95.00 to $80.00 and set a “buy” rating on the stock in a report on Friday, September 19th.

Semler Scientific Price Performance

Semler Scientific stock opened at $20.34 on Friday. The stock has a market capitalization of $310.80 million, a price-to-earnings ratio of 7.32 and a beta of 1.32. Semler Scientific has a 52-week low of $14.89 and a 52-week high of $66.50. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.95 and a current ratio of 1.97. The stock’s 50 day moving average price is $20.12 and its two-hundred day moving average price is $28.01.

Semler Scientific (NASDAQ:SMLR) last released its earnings results on Wednesday, November 12th. The company reported $1.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.14) by $1.21. The company had revenue of $7.49 million for the quarter, compared to the consensus estimate of $7.87 million. Semler Scientific had a net margin of 130.80% and a return on equity of 34.21%.

Institutional Trading of Semler Scientific

Several hedge funds have recently bought and sold shares of SMLR. Russell Investments Group Ltd. increased its stake in Semler Scientific by 80.0% during the 3rd quarter. Russell Investments Group Ltd. now owns 1,753 shares of the company’s stock valued at $53,000 after purchasing an additional 779 shares in the last quarter. Police & Firemen s Retirement System of New Jersey grew its holdings in shares of Semler Scientific by 75.5% during the second quarter. Police & Firemen s Retirement System of New Jersey now owns 1,674 shares of the company’s stock valued at $65,000 after buying an additional 720 shares during the last quarter. Tower Research Capital LLC TRC increased its position in shares of Semler Scientific by 354.8% during the second quarter. Tower Research Capital LLC TRC now owns 1,819 shares of the company’s stock worth $70,000 after acquiring an additional 1,419 shares in the last quarter. Optiver Holding B.V. bought a new stake in shares of Semler Scientific during the third quarter worth about $77,000. Finally, AlphaQuest LLC raised its holdings in shares of Semler Scientific by 446.2% in the 3rd quarter. AlphaQuest LLC now owns 3,419 shares of the company’s stock worth $103,000 after acquiring an additional 2,793 shares during the last quarter. Institutional investors and hedge funds own 49.37% of the company’s stock.

About Semler Scientific

Semler Scientific, Inc, headquartered in Princeton, New Jersey, is a medical technology company specializing in the development and commercialization of non-invasive monitoring solutions for intracranial pressure. The company’s core focus is on improving patient care in neurocritical and acute care settings by providing clinicians with advanced diagnostic tools that reduce the risks associated with invasive procedures.

The company’s flagship product, the NICO Monitor, employs proprietary acoustic monitoring technology to continuously estimate intracranial pressure and compliance at the bedside.